Bellevue Group’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-25,000
| Closed | -$1.54M | – | 218 |
|
|
2019
Q4 | $1.54M | Buy |
+25,000
| New | +$1.54M | 0.02% | 141 |
|
|
2017
Q3 | – | Sell |
-19,000
| Closed | -$1.02M | – | 132 |
|
|
2017
Q2 | $1.02M | Buy |
+19,000
| New | +$1.02M | 0.12% | 102 |
|
|
2017
Q1 | – | Sell |
-20,500
| Closed | -$818K | – | 133 |
|
|
2016
Q4 | $818K | Sell |
20,500
-25,000
| -55% | -$998K | 0.17% | 94 |
|
|
2016
Q3 | $2.21M | Buy |
45,500
+25,000
| +122% | +$1.21M | 0.4% | 72 |
|
|
2016
Q2 | $796K | Buy |
20,500
+2,500
| +14% | +$97.1K | 0.15% | 103 |
|
|
2016
Q1 | $736K | Buy |
+18,000
| New | +$736K | 0.13% | 101 |
|